Celltrion
068270.KS
#659
Rank
A$46.77 B
Marketcap
$225.83
Share price
3.23%
Change (1 day)
32.27%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.51

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.48. In 2022 the company made an earnings per share (EPS) of $4.37 a decrease over its 2021 EPS that were of $5.19.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.513.27%
2022$4.37-15.84%
2021$5.1912.77%
2020$4.6070.79%
2019$2.6915.63%
2018$2.33-33.13%
2017$3.48141.17%
2016$1.448.28%
2015$1.3311.28%
2014$1.2016.37%
2013$1.03-67.42%
2012$3.1684.22%
2011$1.7262.13%
2010$1.0680.61%
2009$0.59-559.63%
2008-$0.13-123.16%
2007$0.55